PB Fintech Share Price: Policybazaar and Paisabazaar’s parent company PB Fintech Ltd (NSE: POLICYBZR) is in the news these days for its plan to enter the healthcare sector.
Yashish Dahiya, the company’s chairman and group CEO, told their partner in an interview that this move would depend on the approval of the board. He also clarified that PB Fintech Ltd will join this new healthcare company as a minority investor.
Last week PB Fintech co-founder and executive vice president Alok Bansal also said that his intention is not to own hospitals but to improve the healthcare experience.
However, PB Fintech Ltd share has seen a decline of about 15% in the last week. However, this stock has given a return of more than 100% so far this year.
Yashish Dahiya further said that PB Fintech Ltd can make a one-time investment of up to $100 million (about Rs 837 crore) for a 20% to 30% stake in the new healthcare company, but this investment will be based on the board approval of the company. He also said that this would be a one-time investment and the company has no intention of investing again.
However, a brokerage firm retained an “outperform” rating on PB Fintech Ltd and kept its price target at Rs 1,760. The firm claims that investors have sunk money into PB Fintech because of its rapid growth, strong business model, as well as its cash generation.
But this move of the company may be seen by some investors as a significant change from its capital-light business model, which is currently putting pressure on its shares.
Now all eyes are on the board meeting of PB Fintech, where it will be decided whether the company will enter the healthcare sector or not. Meanwhile, shares of PB Fintech were trading at Rs 1,713.70, up over 4 percent in early trade today (30 September).
Quick Fact
| Company name | PB Fintech |
|---|---|
| Parent of | Policybazaar, Paisabazaar |
| CEO | Yashish Dahiya |
| Co-founder and EVP | Alok Bansal |
| Sector | Fintech, Insurance |
| Planned new sector | Healthcare |
| Planned role in healthcare | Minority investor |
| Expected stake | 20% to 30% |
| Planned investment | ₹837 crore (one-time) |
| Investment time | One-time |
| Healthcare move | Improve healthcare experience |
| Current stock performance | Down 15% in the last week |
| Stock performance this year | More than 100% up |
| Brokerage firm rating | Outperform |
| Possible target price | ₹1,760 |
| Business model concern | Capital-light |
| Upcoming event | Board meeting on healthcare entry |
Disclaimer: The website and its content are for informational purposes only and should not be considered
